for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD)
continues to be an enormous medical and societal challenge, claiming millions of lives …

Background The benefit of an implantable cardioverter–defibrillator (ICD) in patients with
symptomatic systolic heart failure caused by coronary artery disease has been well …

There is an increasing awareness that sex is a major determinant of the incidence,
aetiology, and clinical presentation of arrhythmias, and that there are sex differences in …

Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …

Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

Cardiac resynchronization therapy (CRT) was proposed in the 1990s as a new therapy for
patients with heart failure and wide QRS with depressed left ventricular ejection fraction …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Sudden cardiac arrest due to lethal ventricular arrhythmias is a major cause of mortality
worldwide and results in more years of potential life lost than any individual cancer. Most of …

Heart failure is a common syndrome associated with substantial morbidity and mortality. The
management of symptoms and the strategies for improving prognosis have largely been …